Ani Pharmaceuticals (ANIP) Stock
$71.25
+5.10% Close Nov 10
ANIP stock is in a downtrend, sits in Stage 1 basing, and does not meet the Minervini Trend Template.
Open interactive chartANIP stock price and performance
ANIP stock trades on NASDAQ and is classified in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. The live price table and chart on this page show current quotes, returns and moving-average lines. Readers can use them to follow how the price moves session by session. This page describes the trend state and the rules behind it.
- Last close
- $71.25
- Day range
- $67.53 to $71.36
- 52-week range
- $67.14 to $90.87
- From 52-week high
- −21.6%
- Average volume (50 days)
- 415,097
- 1 week
- −1.4%
- 1 month
- −3.2%
- 3 months
- −5.2%
- Year to date
- −9.7%
- 1 year
- −21.2%
- 3 years
- +8.9%
- 5 years
- +25.3%
Is ANIP stock in an uptrend?
No, ANIP stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.
ANIP stock is in a downtrend by the trend rules on this page. It does not meet the Minervini Trend Template. The Daily Pivot Breakout momentum filters measure the 100-day rate of change and the 100-day EMA slope, each compared with a minimum. The Weinstein stage is Stage 1 (basing), a phase that uses the 30-week moving average and Mansfield relative strength to show whether a stock is building a base.
- Daily Pivot momentum filters
- 0 of 2 active
- 100-day ROC
- −10.4% filter at 40%: off
- 100-day EMA slope
- −6.3% filter at 25%: off
- Trend state
- Downtrend
- Minervini Trend Template
- Not met on the latest scan
- 50-day average
- Below
- 150-day average
- Below
- 200-day average
- Below
- 200-day slope (1 month)
- −1.39%
- ATR (14) % of price
- 3.64%
Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.
Is ANIP stock in a Stage 2 uptrend?
Not yet. ANIP stock is in Stage 1 (basing) by our Weinstein stage analysis: its 30-week moving average has flattened after a decline.
- Weinstein stage
- Stage 1 (basing)
- 30-week SMA
- $76.91
- 30-week slope (4 weeks)
- −0.99%
- Mansfield RS vs SPY
- -12.12
Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.
ANIP support and resistance levels
ANIP stock has pivot high, pivot low and moving-average lines shown in the levels table. The table lists the distance between the current price and each line, so readers can compare them directly. Support and resistance readings come from these reference lines.
| Level | Price | From close |
|---|---|---|
| 150-day SMA | $77.31 | +8.5% |
| 200-day SMA | $77.15 | +8.3% |
| 30-week SMA | $76.91 | +7.9% |
| Daily Pivot resistance (pivot high) | $74.15 | +4.1% |
| 50-day SMA | $72.38 | +1.6% |
| 21-day EMA | $71.27 | +0.0% |
| 9-day EMA | $70.33 | −1.3% |
| Latest Daily Pivot low | $69.90 | −1.9% |
Levels above the close act as resistance, levels below as support. Last close $71.25.
ANIP breakout and scanner signals
The page tracks the VCP, RSI Divergence, Weinstein Stage Analysis, Daily Pivot Breakout, Minervini Trend Template, Episodic Pivot, Ichimoku TK cross, 9/21 EMA cross, Golden / Death Cross and RS Rating scanners. The signal table lists the dates and directions of signals from these scanners for ANIP stock. Each scanner looks for a different pattern, from trend alignment to momentum and crossover events.
| Scanner | Last signal (free view, 5 sessions late) | Past year |
|---|---|---|
| VCP | None in the last year | 0 |
| RSI Divergence | Oct 21, 2026 | 1 |
| Weinstein Stage Analysis | Jan 22, 2026 | 38 |
| Daily Pivot Breakout | Oct 17, 2025 | 0 |
| Minervini Trend Template | Jan 16, 2026 | 4 |
| Episodic Pivot | None in the last year | 0 |
| Ichimoku TK cross | Oct 6, 2026 (bearish) | 11 |
| 9/21 EMA cross | Sep 30, 2026 (bearish) | 8 |
| Golden / Death Cross | Aug 27, 2026 (bearish) | 3 |
| RS Rating | None in the last year | 0 |
ANIP seasonality by month
ANIP stock has historically been strongest in April and weakest in December. These monthly patterns come from past price behavior and do not predict future results. Readers can compare them with the trend state and the live price table on this page.
- Jan+6.2%69% up
- Feb+1.1%42% up
- Mar−2.1%42% up
- Apr+13.2%58% up
- May−2.5%42% up
- Jun+3.9%67% up
- Jul−3.7%41% up
- Aug+0.4%41% up
- Sep+2.1%41% up
- Oct−3.4%44% up
- Nov+7.9%58% up
- Dec−5.3%42% up
Average monthly return over 26+ years of stored daily closes, and the share of years each month closed higher.
ANIP earnings history
ANIP stock last reported quarterly earnings on Nov 5, 2026. Results came in above the estimate. The earnings result is one of the inputs in the bullish and bearish factors on this page.
| Reported | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Nov 5, 2026 | $2.18 | $2.70 | +23.9% |
| Aug 7, 2026 | $2.04 | $2.21 | +8.3% |
| Jun 25, 2026 | $-0.14 | $-0.16 | −14.3% |
| May 8, 2026 | $1.30 | $2.05 | +57.7% |
ANIP bull and bear case
Bullish factors for ANIP stock include the Stage 1 (basing) reading, which points to a base that may be forming, and the last reported quarter's results, which came in above the estimate. Bearish factors include the current downtrend state and the failure to meet the Minervini Trend Template.
What looks strong
- No strong points in the trend data on the latest scan.
What looks weak
- Neither Daily Pivot momentum filter is active (100-day ROC -10.4%, 100-day EMA slope -6.3%; the filters need 40% and 25%).
- Does not meet the Minervini Trend Template on the latest scan.
- Price is below the 200-day moving average, which is falling.
- Short interest is 18.41% of shares outstanding.
Drawn only from the data on this page. Not a recommendation.
ANIP news and SEC filings, last 30 days
The filings table lists SEC filings for ANI Pharmaceuticals, Inc. and updates with new filings as they are added. Readers can review the form types and dates listed there. The table is the live source for the company's filing history.
- 8-KQuarterly or annual results; Reg FD disclosure; Exhibits
- 10-QQuarterly report (10-Q)
- 8-KMaterial agreement; New debt; Other events; Exhibits
- 4FORM 4
- 4FORM 4
- 4FORM 4
Source: SEC EDGAR.
ANIP insider trading and risks
The insider table lists insider trades reported for ANIP stock, including the type of transaction and the date. Readers can check the table to see whether insiders have been buying or selling. The table updates as new insider reports are filed.
- Buys, last 90 days
- 0 ($0)
- Sales, last 90 days
- 4 ($840,731)
- Buys, last 12 months
- 0 ($0)
- Sales, last 12 months
- 4 ($840,731)
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15 | Lalwani NikhilDirector, PRESIDENT & CEO | Sale 5,400 shares | $388,206 |
| Sep 29 | CAREY STEPHEN P.SVP & CFO | Sale 2,850 shares | $208,050 |
| Oct 29 | CAREY STEPHEN P.SVP & CFO | Sale 2,850 shares | $207,680 |
| Oct 13 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | Sale 500 shares | $36,795 |
Risk flags from the data
- Short interest is 18.41% of shares outstanding.
Insider trades: SEC Form 4 open-market purchases and sales.
ANIP valuation and fundamentals
The valuation table shows the valuation measures available for ANIP stock. Readers can use the table to compare the stock's valuation figures over time. The measures are listed live on this page and are not summarized here.
- Market cap
- $1.55B
- Enterprise value
- $1.78B
- P/E (trailing)
- 15.1
- P/E (forward)
- 6.9
- PEG
- 0.08
- Price to sales
- 1.63
- Price to book
- 2.50
- EV to EBITDA
- 8.5
- Gross margin
- +62.4%
- Operating margin
- +15.0%
- Profit margin
- +11.1%
- Return on equity
- +20.5%
- Revenue (TTM)
- $978.4M
- Revenue growth (quarter, y/y)
- +25.9%
- Cash
- $377.0M
- Debt
- $626.0M
- Beta
- 0.47
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $883.4M | $78.3M | $185.2M |
| 2024 | $614.4M | −$18.5M | $36.3M |
| 2023 | $486.8M | $18.8M | $86.6M |
| 2022 | $316.4M | −$47.9M | −$45.8M |
ANIP dividends and splits
ANIP stock does not pay a dividend. The dividend table on this page lists dividend dates and amounts when payments are recorded. Readers who need income from ANIP stock will not find a payment history here.
- Dividend yield
- 0.00%
- Payout ratio
- 0.0%
Stock splits: 1-for-6 split on Jul 18, 2013, 1-for-6 split on Jun 4, 2012, 1-for-10 split on Jun 3, 2002.
Who owns ANIP?
- Shares outstanding
- 23.0M
- Float
- 19.7M
- Held by insiders
- +5.4%
- Held by institutions
- +107.7%
- Short interest (% of shares)
- +18.4%
- Days to cover
- 8.2
What does Ani Pharmaceuticals, Inc. do?
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures and commercializes branded, generic and specialty prescription medicines. Its three focus areas are Rare Disease, Generics and Established Brands. The portfolio spans ophthalmology, rheumatology, nephrology, neurology and pulmonology. The company also offers contract manufacturing and pharmaceutical development services using U.S.-based facilities.
- CEO
- Mr. Nikhil Lalwani
- Employees
- 970
- Headquarters
- Baudette, MN, United States
- Website
- anipharmaceuticals.com
ANIP stock FAQ
Is ANIP stock in an uptrend?
No, ANIP stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.
Is ANIP stock in a Stage 2 uptrend?
Not yet. ANIP stock is in Stage 1 (basing) by our Weinstein stage analysis: its 30-week moving average has flattened after a decline.
Does ANIP stock meet the Minervini Trend Template?
ANIP stock does not meet the Minervini Trend Template by the rules on this page. The Template checks the stacking order of the 50-day, 150-day and 200-day moving averages and the stock's position in its yearly range. The trend section lists these checks in full.
What are ANIP stock's support and resistance levels?
ANIP stock's support and resistance levels are shown in the levels table through pivot highs, pivot lows and moving-average lines. The table lists the distance from the current price to each line.
When did ANIP last report earnings?
ANIP stock last reported quarterly earnings on Nov 5, 2026. Results came in above the estimate. The earnings section on this page gives the same date and result.
Are insiders buying or selling ANIP stock?
The insider table on this page lists insider trades for ANIP stock, with transaction types and dates. The table updates as new insider reports are filed.
What is ANIP stock's best and worst month historically?
ANIP stock has historically been strongest in April and weakest in December. These patterns come from past price behavior and do not predict future results. The seasonality section on this page covers the same months.
Does ANIP stock pay a dividend?
ANIP stock does not pay a dividend. The dividend table lists dividend dates and amounts when payments are recorded. Readers can check that table for any payment history.
What are the main bullish and bearish factors for ANIP stock?
Bearish factors include the downtrend state and the failure to meet the Minervini Trend Template. The bullbear section lists these factors in full.
What does ANI Pharmaceuticals do?
ANI Pharmaceuticals, Inc. develops, manufactures and commercializes branded, generic and specialty prescription medicines. It focuses on Rare Disease, Generics and Established Brands. The company also provides contract manufacturing and pharmaceutical development services.
What sector and industry is ANIP stock in?
ANIP stock is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry on NASDAQ. The price section on this page gives the same classification. The live price table and chart show the current market data.
